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a  b  s  t  r  a  c  t
Hypertension  is common  in renal  transplant  patients  and  sometimes  very  difﬁcult  to  control.  Refractory
hypertension  can  adversely  affect  renal  graft  and  patient  survival.  Many  antihypertensive  medications
are  not  well  tolerated  or  can  have  important  drug  interactions  with  immunosuppressive  medications.
These  drugs  can  cause  signiﬁcant  side effects  including  ﬂuid  depletion,  azotemia,  electrolyte  imbalance,
and  anemia.  Bilateral  native  nephrectomy  in  renal  transplant  patients  has  been  reported  to  be beneﬁcial
in  controlling  severe  hypertension.
We  report  ﬁve  patients  with  severe  hypertension  despite  as  many  as  9  different  antihypertensive
medications.  All patients  had previous  kidney  or  simultaneous  kidney  pancreas  transplantation.  Each  of
our patients  underwent  laparoscopic  bilateral  native  nephrectomy.
Renal function  varied  from  creatinine  of  1.4–2.4,  and  the  number  of  antihypertensive  medications  from
3  to 9 at  the  time  of  nephrectomy  surgery.  Mean  arterial  blood  pressure  improved  in  all  ﬁve patients  at
3–6 months  post  nephrectomy,  the  number  of  antihypertensive  medications  decreased  in  4,  but renal
function  remained  stable  at 3–6  months  in only  3 patients.
We  found  laparoscopic  bilateral  native  nephrectomy  to be beneﬁcial  in  renal  and simultaneous  kidney
pancreas  transplant  patients  with  severe  and  refractory  hypertension.  Our  patients  with  better  baseline
renal  allograft  function  at time  of  nephrectomy  received  the  most  beneﬁt.  No  decrease  in allograft  function
could  be attributed  to acute  rejection.
© 2015  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Hypertension is common and sometimes difﬁcult to control
ollowing renal transplantation or kidney pancreas transplanta-
ion. Hypertension can signiﬁcantly affect both kidney allograft
unction and patient survival if it is not effectively controlled.
ntihypertensive medications may  not be well-tolerated due
o signiﬁcant side effects. Diuretics can cause ﬂuid depletion,
zotemia, and electrolyte imbalance. Calcium blockers inter-
ct with calcineurin inhibitors, angiotensin-converting enzyme
nhibitors and angiotensin receptor blockers can cause hyper-
alemia and anemia. Vasodilators can result in signiﬁcant edema
ndsympatholytic antihypertensives usually have CNS side effects
Fig. 1).
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210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Assoc
reativecommons.org/licenses/by-nc-nd/4.0/).There have been several case reports in the literature suggesting
that bilateral native nephrectomy can be beneﬁcial in patients with
severe resistant hypertension following renal transplant [1–7].
2. Presentation of cases
We report ﬁve patients with severe hypertension refractory
to multiple antihypertensive medications, all eventually under-
went laparoscopic bilateral native nephrectomy. Three of our
patients had simultaneous kidney pancreas transplant prior to
their bilateral native nephrectomy. All ﬁve patients were receiv-
ing immunosuppresion with tacrolimus. Mychophenolate, and
low dose prednisone. No patient was  considered a candidate for
bilateral nephrectomy pre transplant because they did not have
refractory hypertension prior to transplant. All 5 patients had
hypertension prior to transplant. All patents were screened for
renal artery stenosis using Doppler ultrasound and/or arteriograms.
Noncompliance with medication was  felt unlikely as they had
refractory hypertension in the hospital where medication compli-
ance was observed (Fig. 2).
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Table 1
Demographics.
Age Sex Race Disease Transplant
58 F C DM KP
52  M AA FSGS K
60  M C DM KP
49  M C DM KP
50  M AA HTN K
Fig. 1. Shows MAP  in our patients pre-and post nephrectomy.
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Table 1 shows the age, sex, race, etiology of native kidney dis-
ase, and type of transplant in our patients.
. Discussion
All ﬁve of our patients had an uncomplicated postoperative
ourse following their bilateral native nephrectomy. There was
o postoperative hemorrhage, postoperative infections, pulmonary
mboli; all patients underwent careful preoperative studies to
xclude other causes for refractory hypertension such as trans-
lant renal artery stenosis and adrenal tumors as well as medication
oncompliance (Fig. 3).
Bilateral native nephrectomy was beneﬁcial in reducing mean
rterial pressure in all ﬁve patients, and decreasing the number
ntihypertensive meds in 4 patients. Renal function remained sta-
le in 3 patients, but decreased in two. The 3 patients who beneﬁted
he most i.e., improvement in BP, decrease or no increase in num-
er antihypertensive meds, and stable renal function had a lower
aseline creatinine at the time of bilateral nephrectomy. The two
atients with higher baseline creatinine levels had improved BP
evels but not less antihypertensive meds and lost kidney func-Fig. 3. Compares serum creatinine pre and post nephrectomy for all 5 patients.
tion. The latter two  patients had transplant kidney biopsies after
nephrectomy showing chronic changes without acute rejection.
4. Conclusion
Hypertension is not uncommon in patients after kidney or
kidney–pancreas transplantation. Severe refractory hypertension
is an uncommon but can cause serious post transplant com-
plications which can lead to decrease kidney graft and patient
survival. These patients must have careful evaluation to exclude
treatable causes such as salt abuse, transplant renal artery steno-
sis, adrenal tumors, and medication nonadherance. Aggressive
medical management must always be tried but when severe hyper-
tension persists despite 3 or more antihypertensive medications
including diuretics, calcium blockers, and angiotensin receptor
inhibitors/angiotensin receptor blockers, bilateral native nephrec-
tomy should be considered in these patients.
Our results conﬁrm that bilateral nephrectomy is beneﬁcial in
improving refractory severe hypertension. It appears that patients
with better baseline allograft function receive the most beneﬁt. The
worse the allograft function at the time of bilateral nephrectomy
the less likely renal function will remain stable and the number of
antihypertensive medications can be reduced.
We  acknowledge our study is small, but with multiple and
newer powerful antihypertensive medications only a few patients
are likely to require bilateral nephrectomy. It should however be
considered in appropriate patients earlier rather than later prior to
signiﬁcant decrease in allograft function.
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